These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 24969458

  • 1. [Induction in vitro and stability of Mycobacterium tuberculosis resistance to ofloxacin].
    Yang H, Hu Z, Sha W, Lu J, Cui Z, Wang J, Huang X, Xiao H.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Apr; 48(4):318-23. PubMed ID: 24969458
    [Abstract] [Full Text] [Related]

  • 2. Prevalence of gyrA and B gene mutations in fluoroquinolone-resistant and -sensitive clinical isolates of Mycobacterium tuberculosis and their relationship with MIC of ofloxacin.
    Singh P, Jain A, Dixit P, Prakash S, Jaiswal I, Venkatesh V, Singh M.
    J Antibiot (Tokyo); 2015 Jan; 68(1):63-6. PubMed ID: 25052485
    [Abstract] [Full Text] [Related]

  • 3. Comparison of gyrA gene mutations between laboratory-selected ofloxacin-resistant Mycobacterium tuberculosis strains and clinical isolates.
    Sun Z, Zhang J, Zhang X, Wang S, Zhang Y, Li C.
    Int J Antimicrob Agents; 2008 Feb; 31(2):115-21. PubMed ID: 18164184
    [Abstract] [Full Text] [Related]

  • 4. Correlating Minimum Inhibitory Concentrations of ofloxacin and moxifloxacin with gyrA mutations using the genotype MTBDRsl assay.
    Kambli P, Ajbani K, Sadani M, Nikam C, Shetty A, Udwadia Z, Rodwell TC, Catanzaro A, Rodrigues C.
    Tuberculosis (Edinb); 2015 Mar; 95(2):137-41. PubMed ID: 25522842
    [Abstract] [Full Text] [Related]

  • 5. Performance of Sequencing in Predicting Ofloxacin Resistance in Mycobacterium tuberculosis from Positive Bactec MGIT 960 Cultures.
    Wang Z, Xie T, Mu C, Sun R, Wang C, Zhao H, Ju H.
    Ann Clin Lab Sci; 2018 Jan; 48(1):69-74. PubMed ID: 29530999
    [Abstract] [Full Text] [Related]

  • 6. Molecular characteristics of ofloxacin mono-resistant Mycobacterium tuberculosis isolates from new and previously treated tuberculosis patients.
    Wang Z, Xie T, Mu C, Wang C, Ju H, Zhao H, Sun R.
    J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28317169
    [Abstract] [Full Text] [Related]

  • 7. Analysis of fluoroquinolone resistance in clinical isolates of Mycobacterium tuberculosis from India.
    Sulochana S, Narayanan S, Paramasivan CN, Suganthi C, Narayanan PR.
    J Chemother; 2007 Apr; 19(2):166-71. PubMed ID: 17434825
    [Abstract] [Full Text] [Related]

  • 8. Stepwise decrease in moxifloxacin susceptibility amongst clinical isolates of multidrug-resistant Mycobacterium tuberculosis: correlation with ofloxacin susceptibility.
    Kam KM, Yip CW, Cheung TL, Tang HS, Leung OC, Chan MY.
    Microb Drug Resist; 2006 Apr; 12(1):7-11. PubMed ID: 16584301
    [Abstract] [Full Text] [Related]

  • 9. Molecular detection of fluoroquinolone resistance-associated gyrA mutations in ofloxacin-resistant clinical isolates of Mycobacterium tuberculosis from Iran and Belarus.
    Arjomandzadegan M, Titov L, Farnia P, Owlia P, Ranjbar R, Sheikholeslami F, Surkova L.
    Int J Mycobacteriol; 2016 Sep; 5(3):299-305. PubMed ID: 27847014
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. gyrA and gyrB mutations in ofloxacin-resistant Mycobacterium tuberculosis clinical isolates in Thailand.
    Pitaksajjakul P, Worakhunpiset S, Chaiprasert A, Boonyasopun J, Ramasoota P.
    Southeast Asian J Trop Med Public Health; 2011 Sep; 42(5):1163-7. PubMed ID: 22299442
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Analysis of mutations in the gyrA and gyrB genes and their association with the resistance of Mycobacterium tuberculosis to levofloxacin, moxifloxacin and gatifloxacin.
    Nosova EY, Bukatina AA, Isaeva YD, Makarova MV, Galkina KY, Moroz AM.
    J Med Microbiol; 2013 Jan; 62(Pt 1):108-113. PubMed ID: 23019190
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Wild-Type and Non-Wild-Type Mycobacterium tuberculosis MIC Distributions for the Novel Fluoroquinolone Antofloxacin Compared with Those for Ofloxacin, Levofloxacin, and Moxifloxacin.
    Yu X, Wang G, Chen S, Wei G, Shang Y, Dong L, Schön T, Moradigaravand D, Parkhill J, Peacock SJ, Köser CU, Huang H.
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5232-7. PubMed ID: 27324769
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Mutations in gyrA and gyrB among Fluoroquinolone- and Multidrug-Resistant Mycobacterium tuberculosis Isolates.
    Chien JY, Chiu WY, Chien ST, Chiang CJ, Yu CJ, Hsueh PR.
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2090-6. PubMed ID: 26787695
    [Abstract] [Full Text] [Related]

  • 18. [Molecular characterization of drug-resistant and extensive-drug resistant isolates of Mycobacterium tuberculosis in Shenzhen of China].
    Gui J, Wang F, Luo DQ, Wang HF, Peng Y, Zhang L.
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Apr; 33(4):276-9. PubMed ID: 20646459
    [Abstract] [Full Text] [Related]

  • 19. Characterization of multiple and extensively drug resistant Mycobacterium tuberculosis isolates with different ofloxacin-resistance levels.
    Chernyaeva E, Fedorova E, Zhemkova G, Korneev Y, Kozlov A.
    Tuberculosis (Edinb); 2013 May; 93(3):291-5. PubMed ID: 23491718
    [Abstract] [Full Text] [Related]

  • 20. In Vitro Activity of a Novel Quinolone, UB-8902, Against Ofloxacin-Resistant Mycobacterium tuberculosis Isolates.
    Tudó G, Lopez-Gavin A, Portell-Buj E, Freixes J, Vila J, Roman A, Monté MR, Gonzalez-Martin J.
    Microb Drug Resist; 2020 Sep; 26(9):1019-1022. PubMed ID: 32159449
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.